person

Mélissa B.

Country
France
Department
ONCOLOGIE

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
16
Sites with multiple studies

Has run more than one trial at 16 of 136 partner sites.

Specializations

Lymphoma Research

This investigator specializes in treating various forms of lymphoma, with particular emphasis on anaplastic large cell lymphoma (ALCL) and classical Hodgkin lymphoma in pediatric and young adult patients.

  • ALK-positive ALCL treatment strategies
  • Vinblastine monotherapy approaches
  • Relapsed/refractory lymphoma management

The research extends to innovative immunotherapy applications, including the use of nivolumab for consolidative treatment.

Pediatric Oncology

Focused on developing targeted therapies for young patients, the investigator works extensively with immunotherapy treatments and pembrolizumab applications in pediatric cancer care.

  • Standard risk assessment protocols
  • Long-term treatment strategies
  • Response evaluation methods

Special attention is given to developing age-appropriate treatment protocols for children and adolescents.

Pain Management

The investigator explores advanced pain management solutions, particularly for sickle cell disease related complications in pediatric emergency settings.

  • Intranasal analgesic administration
  • Vaso-occlusive crisis treatment
  • Emergency pain protocols

Research includes comparative studies of different analgesic delivery methods and their effectiveness in acute pain scenarios.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.